Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
188116-07-6
|
| gptkbp:hasApplication |
aging research
cancer research |
| gptkbp:hasMolecularFormula |
C23H19N3O3
|
| gptkbp:hasSMILES |
C1=CC=C2C(=C1)C=CC=C2C/C=C/C(=O)NC3=CC=CC=C3C(=O)O
|
| gptkbp:heldBy |
telomerase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
BIBR1532
|
| gptkbp:IUPACName |
2-[(E)-3-naphthalen-2-yl-but-2-enoylamino]-benzoic acid
|
| gptkbp:mechanismOfAction |
inhibits telomerase activity
|
| gptkbp:molecularWeight |
385.42 g/mol
|
| gptkbp:PubChem_CID |
5311107
CHEMBL25436 |
| gptkbp:studies |
anticancer properties
telomere shortening effects |
| gptkbp:bfsParent |
gptkb:telomerase_complex
gptkb:Telomerase |
| gptkbp:bfsLayer |
7
|